Kars Medical Group expands dental implant production in Beijing with ¥110 million investment

Kars Medical Group has formally initiated a project to expand its dental implant medical device product development and production service at its existing facility in the International Biomedical Park in Beijing's Daxing area, with a total investment of ¥110 million and expected annual capacity of 2 million units.

“该项目位于国际生物医药园2号楼现有厂房，建筑面积8493平方米，总投资1.1亿元，将建设医疗器械CDMO创新服务中心，重点开展口腔种植体等植（介）入类医疗器械产品的工艺开发、规模化生产及质量控制等业务。”open.beijing.gov.cn

• 1 source
• open.beijing.gov.cn开放北京Feb 2, 2026

Summarized from public sources; check the original articles before acting on it.